PAPER Li D, McIntosh CS, Mastaglia FL, Wilton SD, Aung-Htut MT

Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies.

Transl Neurodegener. 2021 May 20;10(1):16. PubMed. Correction.

PAPER Bayer D, Antonucci S, Müller HP, Saad R, Dupuis L, Rasche V, Böckers TM, Ludolph AC, Kassubek J, Roselli F

Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients.

Transl Neurodegener. 2021 May 31;10(1):17. PubMed.

PAPER Aksnes M, Aass HC, Tiiman A, Edwin TH, Terenius L, Bogdanović N, Vukojević V, Knapskog AB

Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer's disease.

Transl Neurodegener. 2021 Jun 8;10(1):18. PubMed.

PAPER Ma KY, Fokkens MR, Reggiori F, Mari M, Verbeek DS

Parkinson's disease-associated VPS35 mutant reduces mitochondrial membrane potential and impairs PINK1/Parkin-mediated mitophagy.

Transl Neurodegener. 2021 Jun 15;10(1):19. PubMed.

PAPER Liu D, Guo JJ, Su JH, Svanbergsson A, Yuan L, Haikal C, Li W, Gouras G, Li JY

Differential seeding and propagating efficiency of α-synuclein strains generated in different conditions.

Transl Neurodegener. 2021 Jun 21;10(1):20. PubMed.

PAPER Han JL, Pang KK, Ang SR, Sharma M, Sajikumar S

Inhibition of lysine methyltransferase G9a/GLP reinstates long-term synaptic plasticity and synaptic tagging/capture by facilitating protein synthesis in the hippocampal CA1 area of APP/PS1 mouse model of Alzheimer's disease.

Transl Neurodegener. 2021 Jun 29;10(1):23. PubMed.

PAPER Pagnoni I, Gobbi E, Premi E, Borroni B, Binetti G, Cotelli M, Manenti R

Language training for oral and written naming impairment in primary progressive aphasia: a review.

Transl Neurodegener. 2021 Jul 16;10(1):24. PubMed.

PAPER He S, Huang L, Shao C, Nie T, Xia L, Cui B, Lu F, Zhu L, Chen B, Yang Q

Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease.

Transl Neurodegener. 2021 Jul 28;10(1):25. PubMed.

PAPER Bi FC, Yang XH, Cheng XY, Deng WB, Guo XL, Yang H, Wang Y, Li J, Yao Y

Optimization of cerebral organoids: a more qualified model for Alzheimer's disease research.

Transl Neurodegener. 2021 Aug 9;10(1):27. PubMed.

PAPER Shen D, Yang X, Wang Y, He D, Sun X, Cai Z, Li J, Liu M, Cui L

The Gold Coast criteria increases the diagnostic sensitivity for amyotrophic lateral sclerosis in a Chinese population.

Transl Neurodegener. 2021 Aug 9;10(1):28. PubMed.

PAPER Xu X, Shen D, Gao Y, Zhou Q, Ni Y, Meng H, Shi H, Le W, Chen S, Chen S

A perspective on therapies for amyotrophic lateral sclerosis: can disease progression be curbed?

Transl Neurodegener. 2021 Aug 10;10(1):29. PubMed.

PAPER Witzel S, Frauhammer F, Steinacker P, Devos D, Pradat PF, Meininger V, Halbgebauer S, Oeckl P, Schuster J, Anders S, Dorst J, Otto M, Ludolph AC

Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials.

Transl Neurodegener. 2021 Aug 26;10(1):31. PubMed.

PAPER Pyun JM, Park YH, Lee KJ, Kim S, Saykin AJ, Nho K, Alzheimer’s Disease Neuroimaging Initiative

Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.

Transl Neurodegener. 2021 Aug 31;10(1):32. PubMed.

PAPER Wilkins HM, Swerdlow RH

Mitochondrial links between brain aging and Alzheimer's disease.

Transl Neurodegener. 2021 Sep 1;10(1):33. PubMed.

PAPER Bao Y, Yang X, Fu Y, Li Z, Gong R, Lu W

NMDAR-dependent somatic potentiation of synaptic inputs is correlated with β amyloid-mediated neuronal hyperactivity.

Transl Neurodegener. 2021 Sep 8;10(1):34. PubMed.